SCHEMBL899883

SCHEMBL899883

CN1CCC(Oc2ccccc2CC(=O)O)CC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 3/20 0.66
KDM4E B2RXH2 3/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
NPY1R P25929 1/20 0.56
NPY2R P49146 1/20 0.56
SCN1A P35498 5/20 0.53
SCN2A Q99250 5/20 0.53
SCN3A Q9NY46 5/20 0.53
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
CHRM3 P20309 4/20 0.51
CHRM1 P11229 2/20 0.51
CHRM4 P08173 1/20 0.51
CHRM5 P08912 1/20 0.51
MAPT P10636 2/20 0.50
ALDH1A1 P00352 2/20 0.50
LMNA P02545 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
MLNR O43193 1/20 0.46
CHRM2 P08172 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12985402 0.87 CXCL8 (0.53) HRH1CHRM1SLC6A3KCNH2CXCL8
SCHEMBL900406 0.84 HRH1 (0.58) HRH1KDM4ESMN1; SMN2NPY1RNPY2R
SCHEMBL20576649 0.84 HRH1 (0.52) HRH1KDM4ESMN1; SMN2NPY1RNPY2R
SCHEMBL14624279 0.84 HRH1 (0.62) HRH1KDM4ESMN1; SMN2NPY1RNPY2R
SCHEMBL16295743 0.80 KDM4E (0.59) HRH1KDM4ESMN1; SMN2NPY1RNPY2R
SCHEMBL11389529 0.80 HRH1 (0.65) HRH1SLC6A3KCNH2CXCL8
SCHEMBL3289933 0.80 HRH1 (0.57) HRH1KDM4ESMN1; SMN2NPY1RNPY2R
Hydrochloric Acid SCHEMBL11402907 0.79 HRH1 (0.63) HRH1SLC6A3KCNH2CXCL8
SCHEMBL12468790 0.79 CXCL8 (0.46) HRH1CHRM1CXCL8
SCHEMBL15057563 0.78 KDM4E (0.60) HRH1KDM4ESMN1; SMN2NPY1RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2621916-B1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET SOC CIV (FR) 2016-02-10 EP disclosed
US-9029357-B2 Benzazole derivatives as histamine H4 receptor ligands BIOPROJET (FR) 2015-05-12 US disclosed
US-20150004181-A1 Benzazole Derivatives as Histamine H4 Receptor Ligands BIOPROJET SOC CIV (FR) 2015-01-01 US disclosed
US-8802664-B2 Benzazole derivatives as histamine H4 receptor ligands BIOPROJECT (FR) 2014-08-12 US disclosed
US-20130231329-A1 Benzazole Derivatives as Histamine H4 Receptor Ligands BIOPROJET (FR) 2013-09-05 US disclosed
EP-2621916-A1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET (FR) 2013-08-07 EP disclosed
EP-2447263-A1 Benzazole derivatives as histamine H4 receptor ligands BIOPROJET (FR) 2012-05-02 EP disclosed
WO-2012041860-A1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET (FR) 2012-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150004181-A1 Benzazole Derivatives as Histamine H4 Receptor Ligands HRH4, HRH3, HRH2 HRH1 4/4885KDM4E 1546/4885SMN1; SMN2 4780/4885
US-20130231329-A1 Benzazole Derivatives as Histamine H4 Receptor Ligands HRH4, HRH3, HRH2 HRH1 4/4885KDM4E 2139/4885SMN1; SMN2 4784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.